INTRODUCTION: The management of older cancer patients is often suboptimal. This study aims to understand the management of older cancer patients who may receive chemotherapy. METHODS: A questionnaire was mailed in 2006-2007 to 181 medical oncologists and hematologists practicing in the Province of Quebec, Canada. Physicians, involved in treatment decisions regarding chemotherapy in cancer patients aged 70 years and older, were eligible. RESULTS: The response rate was 45.7%. Treatment toxicity (24.4%), comorbidities (20.5%), and lack of social support (10.9%) were reported as challenges when caring for older cancer patients. Comorbidities and functional status were reported as principal factors when making treatment decisions regarding chemotherapy; 77.5% of respondents expressed interest in collaborating with geriatricians. CONCLUSIONS: The concerns of respondents about comorbidities, functional status, and social support, along with their interest to collaborate with geriatricians, support the need for a partnership between these two disciplines.
INTRODUCTION: The management of older cancerpatients is often suboptimal. This study aims to understand the management of older cancerpatients who may receive chemotherapy. METHODS: A questionnaire was mailed in 2006-2007 to 181 medical oncologists and hematologists practicing in the Province of Quebec, Canada. Physicians, involved in treatment decisions regarding chemotherapy in cancerpatients aged 70 years and older, were eligible. RESULTS: The response rate was 45.7%. Treatment toxicity (24.4%), comorbidities (20.5%), and lack of social support (10.9%) were reported as challenges when caring for older cancerpatients. Comorbidities and functional status were reported as principal factors when making treatment decisions regarding chemotherapy; 77.5% of respondents expressed interest in collaborating with geriatricians. CONCLUSIONS: The concerns of respondents about comorbidities, functional status, and social support, along with their interest to collaborate with geriatricians, support the need for a partnership between these two disciplines.
Authors: Patricia M Davidson; Moyez Jiwa; Alice J Goldsmith; Sarah J McGrath; Michelle Digiacomo; Jane L Phillips; Meera Agar; Phillip J Newton; David C Currow Journal: Support Care Cancer Date: 2011-05-27 Impact factor: 3.603
Authors: Sattva S Neelapu; Caron A Jacobson; Olalekan O Oluwole; Javier Munoz; Abhinav Deol; David B Miklos; Nancy L Bartlett; Ira Braunschweig; Yizhou Jiang; Jenny J Kim; Lianqing Zheng; John M Rossi; Frederick L Locke Journal: Blood Date: 2020-06-04 Impact factor: 22.113
Authors: Pashna N Munshi; Yue Chen; Kwang W Ahn; Farrukh T Awan; Amanda Cashen; Geoffrey Shouse; Mazyar Shadman; Paul Shaughnessy; Joanna Zurko; Frederick L Locke; Aaron M Goodman; Jose C Villaboas Bisneto; Craig Sauter; Mohamad A Kharfan-Dabaja; Gabrielle Meyers; Samantha Jaglowski; Alex Herrera; Mehdi Hamadani Journal: Transplant Cell Ther Date: 2022-05-21
Authors: Martine T E Puts; Schroder Sattar; Kara McWatters; Katherine Lee; Michael Kulik; Mary-Ellen MacDonald; Raymond Jang; Eitan Amir; Monika K Krzyzanowska; Natasha Leighl; Margaret Fitch; Anthony M Joshua; Padraig Warde; Ann E Tourangeau; Shabbir M H Alibhai Journal: Support Care Cancer Date: 2016-11-09 Impact factor: 3.603